OBI-833, the cancer therapeutic vaccine, has met the primary safety indicators in Phase I clinical trial for US and Taiwan

Date of occurrence of the event: April 6, 2017 Company name: OBI Pharma, Inc. Relationship to the Company (please enter ”head office” or ”affiliated company”): head office Reciprocal shareholding ratios: N/A Name of mass media: N/A Content reported: N/A Cause of occurrence: OBI-833, the cancer therapeutic vaccine, has met the primary safety indicators in Phase […]